201 related articles for article (PubMed ID: 15044746)
21. The presence of spontaneous portosystemic shunts increases the risk of complications after transjugular intrahepatic portosystemic shunt (TIPS) placement.
Borentain P; Soussan J; Resseguier N; Botta-Fridlund D; Dufour JC; Gérolami R; Vidal V
Diagn Interv Imaging; 2016 Jun; 97(6):643-50. PubMed ID: 26947721
[TBL] [Abstract][Full Text] [Related]
22. The use of a polytetrafluoroethylene-covered stent graft for transjugular intrahepatic portosystemic shunt (TIPS): Long-term follow-up of 100 patients.
Rössle M; Siegerstetter V; Euringer W; Olschewski M; Kromeier J; Kurz K; Langer M
Acta Radiol; 2006 Sep; 47(7):660-6. PubMed ID: 16950701
[TBL] [Abstract][Full Text] [Related]
23. Transjugular intrahepatic portosystemic shunt for refractory ascites: an analysis of the literature on efficacy, morbidity, and mortality.
Russo MW; Sood A; Jacobson IM; Brown RS
Am J Gastroenterol; 2003 Nov; 98(11):2521-7. PubMed ID: 14638358
[TBL] [Abstract][Full Text] [Related]
24. Transjugular intrahepatic portosystemic shunt: an analysis of outcomes.
Kurmis TP
ANZ J Surg; 2009 Oct; 79(10):745-9. PubMed ID: 19878172
[TBL] [Abstract][Full Text] [Related]
25. Expanded PTFE-covered stent-grafts in the treatment of transjugular intrahepatic portosystemic shunt (TIPS) stenoses and occlusions.
Echenagusia M; Rodriguez-Rosales G; Simo G; Camuñez F; Bañares R; Echenagusia A
Abdom Imaging; 2005; 30(6):750-4. PubMed ID: 16245017
[TBL] [Abstract][Full Text] [Related]
26. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
[TBL] [Abstract][Full Text] [Related]
27. Acute and chronic complications after implantation of a transjugular intrahepatic portosystemic shunt--a prospective study in 53 patients.
Gschwantler M; Gebauer A; Vavrik J; Madani B; Rohrmoser M; Schrutka-Kölbl C; Brownstone E; Fleischer J; Tscholakoff D; Weiss W
Z Gastroenterol; 1997 Nov; 35(11):999-1005. PubMed ID: 9429285
[TBL] [Abstract][Full Text] [Related]
28. Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment.
Teng D; Zuo H; Liu L; Dong J; Ding L
Virol J; 2018 Oct; 15(1):151. PubMed ID: 30285813
[TBL] [Abstract][Full Text] [Related]
29. Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites.
Deschênes M; Dufresne MP; Bui B; Fenyves D; Spahr L; Roy L; Lafortune M; Pomier-Layrargues G
Am J Gastroenterol; 1999 May; 94(5):1361-5. PubMed ID: 10235219
[TBL] [Abstract][Full Text] [Related]
30. Transjugular intrahepatic portosystemic shunt patency and clinical outcome in patients with Budd-Chiari syndrome: covered versus uncovered stents.
Gandini R; Konda D; Simonetti G
Radiology; 2006 Oct; 241(1):298-305. PubMed ID: 16908675
[TBL] [Abstract][Full Text] [Related]
31. Predictors of early mortality after transjugular intrahepatic portosystemic shunt creation for the treatment of refractory ascites.
Harrod-Kim P; Saad WE; Waldman D
J Vasc Interv Radiol; 2006 Oct; 17(10):1605-10. PubMed ID: 17057001
[TBL] [Abstract][Full Text] [Related]
32. Surgical shunts and TIPS for variceal decompression in the 1990s.
Henderson JM; Nagle A; Curtas S; Geisinger M; Barnes D
Surgery; 2000 Oct; 128(4):540-7. PubMed ID: 11015086
[TBL] [Abstract][Full Text] [Related]
33. Dacron-covered stent-grafts in transjugular intrahepatic portosystemic shunts: initial experience.
Lau CT; Scott M; Stavropoulos SW; Soulen MC; Solomon JA; Clark TW
Radiology; 2005 Aug; 236(2):725-9. PubMed ID: 16000648
[TBL] [Abstract][Full Text] [Related]
34. Transjugular intrahepatic portosystemic shunt for symptomatic refractory hepatic hydrothorax in patients with cirrhosis.
Dhanasekaran R; West JK; Gonzales PC; Subramanian R; Parekh S; Spivey JR; Martin LG; Kim HS
Am J Gastroenterol; 2010 Mar; 105(3):635-41. PubMed ID: 19904245
[TBL] [Abstract][Full Text] [Related]
35. Urgent transjugular intrahepatic portosystemic shunt for control of acute variceal bleeding.
Bañares R; Casado M; Rodríguez-Láiz JM; Camúñez F; Matilla A; Echenagusía A; Simó G; Piqueras B; Clemente G; Cos E
Am J Gastroenterol; 1998 Jan; 93(1):75-9. PubMed ID: 9448179
[TBL] [Abstract][Full Text] [Related]
36. Transjugular intrahepatic portosystemic shunts: adjunctive embolotherapy of gastroesophageal collateral vessels in the prevention of variceal rebleeding.
Tesdal IK; Filser T; Weiss C; Holm E; Dueber C; Jaschke W
Radiology; 2005 Jul; 236(1):360-7. PubMed ID: 15955858
[TBL] [Abstract][Full Text] [Related]
37. Budd-Chiari syndrome: long-term effect on outcome with transjugular intrahepatic portosystemic shunt.
Khuroo MS; Al-Suhabani H; Al-Sebayel M; Al Ashgar H; Dahab S; Khan MQ; Khalaf HA
J Gastroenterol Hepatol; 2005 Oct; 20(10):1494-502. PubMed ID: 16174064
[TBL] [Abstract][Full Text] [Related]
38. Transjugular Intrahepatic Portosystemic Shunt:The Impact of Portal Venous Pressure Declines on Shunt Patency and Clinical Efficacy.
Wan YM; Li YH; Xu ZY; Wu HM; Wu XN; Xu Y; Guo T
Acad Radiol; 2019 Feb; 26(2):188-195. PubMed ID: 29934023
[TBL] [Abstract][Full Text] [Related]
39. [Indicators for longterm survival after the transjugular portosystemic intrahepatic shunt procedure].
Kirchhoff TD; Rosenthal H; Merkesdal S; Ockenga J; Manns MP; Galanski M; Caselitz M
Radiologe; 2002 Sep; 42(9):745-52. PubMed ID: 12244477
[TBL] [Abstract][Full Text] [Related]
40. Transjugular intrahepatic portosystemic shunts for refractory ascites after liver transplantation.
Abouljoud M; Yoshida A; Kim D; Jerius J; Arenas J; Raoufi M; Brown K; Moonka D
Transplant Proc; 2005 Mar; 37(2):1248-50. PubMed ID: 15848685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
